author-photo

Barbara L. Rellahan

Center for Drug Evaluation and Research

2

Papers

121

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

First FDA Approval of Dual Anti-HER2 Regimen: Pertuzumab in Combination with Trastuzumab and Docetaxel for HER2-Positive Metastatic Breast Cancer

2013 Clinical Cancer Research
Show All
- Source
- Cite
- Save
Citations (78)
A New Tyrosine Phosphorylation Site in PLCγ1: The Role of Tyrosine 775 in Immune Receptor Signaling

2005 Journal of Immunology
Show All
- Source
- Cite
- Save
Citations (43)